Skip to content

CRN 2026 Survey: Human Review in AI Supplement Recommendations

October 29, 2026
CRN 2026 Survey: Human Review in AI Supplement Recommendations

A US survey question paired AI supplement recommendations with professional review. For brands, the useful discussion concerns sources, checks and responsibility.

Keep the condition attached to the finding

CRN’s release of 7 October 2026 reports that 45% of US adults would be comfortable with personalized AI supplement recommendations if reviewed by a doctor, pharmacist or registered dietitian.

This industry-commissioned US attitude survey did not test an AI system’s accuracy. It is neither a measure of Hong Kong attitudes nor evidence of supplement efficacy or safety.

Start with an inspectable product information pack

The following workflow suggestions are editorial implications, not findings tested by the survey. Organize product names, versions, ingredients per serving, labels and review dates so that source information can be checked.

A fluent summary can omit a unit or limitation. Retain original document links and name the responsible reviewer. Generated wording should not become an approved product statement simply because it reads confidently.

戴手套的人員使用移液器處理樣本

Gloved person using a pipette to handle a sample. Illustrative photograph by Jess Loiterton / Pexels. Not an ACC Biotech facility or a study of the specified ingredient. Illustrative photograph, not a specified ingredient, product or supply batch.

Build a referral route into customer support

Define the scope of general product information and how to refer questions involving medicines, illness, pregnancy or individual health circumstances. A tool should not infer a person’s requirements or substitute for professional assessment.

For internal trials, use examples without sensitive personal information. Check whether answers identify unknowns, preserve sources and return out-of-scope questions to staff. Evaluate the actual answers, alongside interface convenience.

Make human review an operational step

Assign responsibility for checking sources, labels, versions and market applicability, and record corrections and approvals. Product changes also need a way to update reference material so that an old formula is not silently reused.

These are process ideas for discussion, not solutions validated by this survey. News can frame useful questions; adoption of a particular tool still requires assessment of its actual purpose, data handling and professional responsibilities.

Sources checked 20 October 2026: CRN — 7 October 2026 survey release

Discuss your product brief with ACC Biotech

Bring your target market, ingredient requirements, serving configuration and format to ACC Biotech for a supplement OEM/ODM or sourcing discussion, or enquire via WhatsApp. Specifications, documentation, costs and timing are confirmed for the project.

Cover: Laboratory worker transferring liquid with a pipette. Illustrative photograph by Mikhail Nilov / Pexels. Not an ACC Biotech facility or a study of the specified ingredient. Illustrative image, not the specified ingredient or finished product.